Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Hutchmed
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
6
12
18
24
30
36
42
48
54
60
Tazverik
(tazemetostat) / Eisai, Ipsen
Orpathys
(savolitinib) / AstraZeneca, Hutchmed
sovleplenib
(HMPL-523) / Hutchmed
HMPL-004
/ Hutchmed
HMPL-306
/ Hutchmed
epitinib
(HMPL-813) / Hutchmed